Terug
43
53
36
5
6
4
43
Ook genoteerd als
USSJF
OTC
Dagbereik
€ 21,17
€ 23,75
52-Weeksbereik
€ 17,75
€ 25,25
Volume
166
50D / 200D Gem.
€ 23,09
/
€ 22,96
Vorige Slotkoers
€ 21,17
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 11,2 |
| P/B | 0,0 | 1,4 |
| ROE % | 18,8 | 10,7 |
| Net Margin % | 36,2 | 5,1 |
| Rev Growth 5Y % | 8,6 | 8,3 |
| D/E | 0,0 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
120 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
110 B | 0 |
Belangrijkste Punten
Revenue grew 8,57% annually over 5 years — modest growth
ROE of 18,81% — decent returns on equity
Net margin of 36,18% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 33,89B in free cash flow
P/E of 0,13 — trading at a low valuation
Groei
Revenue Growth (5Y)
8,57%
Revenue (1Y)6,57%
Earnings (1Y)14,37%
FCF Growth (3Y)2,36%
Kwaliteit
Return on Equity
18,81%
ROIC19,69%
Net Margin36,18%
Op. Margin52,11%
Veiligheid
Debt / Equity
0,01
Current Ratio2,83
Interest Coverage6022,89
Waardering
P/E Ratio
0,13
P/B Ratio0,02
EV/EBITDA-1,96
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,57% | Revenue Growth (3Y) | 8,24% |
| Earnings Growth (1Y) | 14,37% | Earnings Growth (3Y) | 11,99% |
| Revenue Growth (5Y) | 8,57% | Earnings Growth (5Y) | 74,90% |
| Profitability | |||
| Revenue (TTM) | 104,02B | Net Income (TTM) | 37,64B |
| ROE | 18,81% | ROA | 14,08% |
| Gross Margin | 62,32% | Operating Margin | 52,11% |
| Net Margin | 36,18% | Free Cash Flow (TTM) | 33,89B |
| ROIC | 19,69% | FCF Growth (3Y) | 2,36% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 2,83 |
| Interest Coverage | 6022,89 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 0,13 | P/B Ratio | 0,02 |
| P/S Ratio | 0,05 | PEG Ratio | 1,15 |
| EV/EBITDA | -1,96 | Dividend Yield | 0,03% |
| Market Cap | 4,91B | Enterprise Value | -106,06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 104,02B | 97,61B | 88,78B | 81,48B | 74,87B |
| Net Income | 37,64B | 32,91B | 30,01B | 29,75B | 4,02B |
| EPS (Diluted) | 157,04 | 136,20 | 122,48 | 119,58 | 16,10 |
| Gross Profit | 64,82B | 59,04B | 53,64B | 50,77B | 46,53B |
| Operating Income | 54,21B | 48,94B | 43,78B | 41,57B | 36,23B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 267,35B | 271,56B | 242,35B | 229,35B | 210,70B |
| Total Liabilities | 60,00B | 72,54B | 48,20B | 46,88B | 37,18B |
| Shareholders' Equity | 204,20B | 196,00B | 191,45B | 180,34B | 171,83B |
| Total Debt | 2,25B | 2,66B | 2,42B | 2,83B | 3,17B |
| Cash & Equivalents | 113,22B | 109,01B | 92,69B | 79,38B | 67,77B |
| Current Assets | 144,64B | 148,37B | 116,06B | 103,87B | 81,53B |
| Current Liabilities | 51,15B | 63,13B | 39,27B | 37,88B | 26,92B |
Strategiescores
This stock passed the criteria for 7 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#566 of 1052
Custom
Capital Light Compounder
#48 of 218
#514 of 827
#599 of 618
#598 of 670
#643 of 709
Custom
Balanced Risk
#90 of 151
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026